NCT07627438 Pelvic Floor Therapies for Lifelong Premature Ejaculation
| NCT ID | NCT07627438 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Premature Ejaculation |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-04-26 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2026-04-26 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial will compare three pelvic floor-based treatment modalities in men with lifelong premature ejaculation: electromagnetic pelvic floor stimulation, biofeedback-assisted pelvic floor muscle training, and conventional pelvic floor muscle training. A total of 150 men aged 18 to 50 years with lifelong premature ejaculation and stopwatch-measured intravaginal ejaculatory latency time of less than 1 minute will be randomly assigned to one of the three treatment groups. The primary outcome will be the change in intravaginal ejaculatory latency time from baseline to the end of treatment at 6 weeks. Secondary outcomes will include changes in Premature Ejaculation Diagnostic Tool score, International Index of Erectile Function-5 score, patient-reported ejaculatory control, sexual satisfaction, partner satisfaction, treatment adherence, and adverse events.
Eligibility Criteria
Inclusion Criteria: * Men aged 18 to 50 years. * Diagnosis of lifelong premature ejaculation. * Intravaginal ejaculatory latency time less than 1 minute. * Ability and willingness to comply with the treatment protocol and follow-up visits. * Written informed consent. Exclusion Criteria: * Erectile dysfunction. * Neurological disease. * Previous pelvic surgery.
Contact & Investigator
Mohamed I Elmaadawy, MD
PRINCIPAL INVESTIGATOR
Tanta University
Frequently Asked Questions
Who can join the NCT07627438 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 50 Years, studying Premature Ejaculation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07627438 currently recruiting?
Yes, NCT07627438 is actively recruiting participants. Contact the research team at Mohamed.elmaadawy@med.tanta.edu.eg for enrollment information.
Where is the NCT07627438 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07627438 clinical trial?
NCT07627438 is sponsored by Tanta University. The principal investigator is Mohamed I Elmaadawy, MD at Tanta University. The trial plans to enroll 150 participants.